Effectiveness and pharmacoeconomic analysis of the treatment of severe asthma with omalizumab in clinical practice.
To assess socio-sanitary expenditure after the addition of omalizumab to standard treatment in the control of severe asthma and to analyse its effectiveness under standard clinical practice.
| Autores: | , , , , , |
|---|---|
| Formato: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2019 |
| País: | España |
| Recursos: | Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL) |
| Repositorio: | r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante |
| OAI Identifier: | oai:isabial.fundanetsuite.com:p3540 |
| Acesso em linha: | https://isabial.portalinvestigacion.com/publicaciones3540 |
| Access Level: | acceso abierto |
| Palavra-chave: | Asthma Cost-benefit analysis Health care costs Omalizumab Quality of life |
| Resumo: | To assess socio-sanitary expenditure after the addition of omalizumab to standard treatment in the control of severe asthma and to analyse its effectiveness under standard clinical practice. |
|---|